Barriers to Counseling Patients with Obesity: A Study of Texas Community Pharmacists

Flegal, 2002, Prevalence and trends in obesity among US adults, 1999–2000, JAMA, 288, 1723, 10.1001/jama.288.14.1723 Small, 2000, Obesity: managing the comorbidities of the disease, J Am Pharm Assoc, 40, S42 Wolf, 1998, Current estimates of the economic cost of obesity in the United States, Obes Res, 6, 97, 10.1002/j.1550-8528.1998.tb00322.x 2000, Healthy people 2010: understanding and improving health, 2 Lyznicki, 2001, Obesity: assessment and management in primary care, Am Fam Physician, 63, 2185 Chandra, 2003, Practicing health promotion through pharmacy counseling activities, Health Promot Pract, 4, 64, 10.1177/1524839902238293 Babb, 2003, Pharmacist involvement in Healthy People 2010, J Am Pharm Assoc, 43, 56, 10.1331/10865800360467051 Campbell, 2003, Unraveling the mysteries of syndrome X, J Am Pharm Assoc, 43, S32 Wadden, 1997, Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach, Obes Res, 5, 218, 10.1002/j.1550-8528.1997.tb00296.x 2001, ASHP Commission on Therapeutics. ASHP therapeutic position statement on the safe use of pharmacotherapy for obesity management in adults, Am J Health Syst Pharm, 58, 1645, 10.1093/ajhp/58.17.1645 Malone, 2003, Pharmacist intervention enhances adherence to orlistat therapy, Ann Pharmacother, 37, 1598, 10.1345/aph.1D183 Ahrens, 2003, Effects of weight reduction interventions by community pharmacists, J Am Pharm Assoc, 43, 583, 10.1331/154434503322452210 Dastani, 2004, Combating the obesity epidemic: community pharmacists' counseling on obesity management, Ann Pharmacother, 38, 1961, 10.1345/aph.1E205 Raisch, 1993, Barriers to providing cognitive services, Am Pharm, NS33, 54, 10.1016/S0160-3450(15)30574-2 Herrier, 1994, Why aren't more pharmacists counseling?, Am Pharm, NS34, 22 Wiese, 1992, Obesity stigma reduction in medical students, Int J Obes, 16, 859 Price, 1987, Family practice physicians' beliefs, attitudes, and practices regarding obesity, Am J Prev Med, 3, 339, 10.1016/S0749-3797(18)31234-0 Smith, 2004, Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications, Am J Health Syst Pharm, 61, 1120, 10.1093/ajhp/61.11.1120 O'Loughlin, 1999, The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease, Prev Med, 28, 324, 10.1006/pmed.1998.0436 Aquilino, 2003, Smoking-cessation services in Iowa community pharmacies, Pharmacotherapy, 23, 666, 10.1592/phco.23.5.666.32192 Williams, 2000, An evaluation of smoking cessation-related activities by pharmacists, J Am Pharm Assoc, 40, 366, 10.1016/S1086-5802(16)31084-1 Ogden, 2001, General practitioners' and patients' models of obesity: whose problem is it?, Patient Educ Couns, 44, 227, 10.1016/S0738-3991(00)00192-0 Harvey, 2001, Health professionals' views of overweight people and smokers, Int J Obes Relat Metab Disord, 25, 1253, 10.1038/sj.ijo.0801647 Li, 2005, Meta-analysis: pharmacologic treatment of obesity, Ann Intern Med, 142, 532, 10.7326/0003-4819-142-7-200504050-00012 Arterburn, 2004, The efficacy and safety of sibutramine for weight loss: a systematic review, Arch Intern Med, 164, 994, 10.1001/archinte.164.9.994 Haddock, 2002, Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials, Int J Obes Relat Metab Disord, 26, 262, 10.1038/sj.ijo.0801889 Frank, 1993, Futility and avoidance: medical professionals in the treatment of obesity, JAMA, 269, 2132, 10.1001/jama.1993.03500160102041 Lyznicki, 2001, Obesity: assessment and management in primary care, Am Fam Physician, 63, 2185